genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Acadia Pharmaceuticals
News
FDA Approves First Treatment for Rett Syndrome
Insights
Stock Watch: The Fabulous Baker Brothers
Insights
From Biotech to Best Sellers
News
Biovail Pays Acadia $8.75M to End Phase III Parkinson Disease Psychosis Drug Pact
News
Acadia Crashes with Negative Results from Phase III Antipsychosis Candidate
News
Acadia to Develop Schizophrenia Treatments with Meiji Seika for Asian Market
News
Vivus Pockets $65M and Kingsbridge Proffers $60M to Acadia as well as $50M to EPIX
Insights
HTS Carving Out Hit-to-Lead Position
Insights
Acadias CNS Pipeline Propels Growth
Scroll Up
Scroll Up
